Health
Insilico Medicine AI COVID tool uses Xeons – Fudzilla
Intel helps in COVID-19 research Industry veteran Alex Zhavoronkov who left the PC industry (ATI and AMD) to start the AI longevity focused Insilico Medicine, has announced AI-powered COVIDomic to power the COVID-19 basic and clinical research.
Insilico Medicine is a global leader in artificial intelligence for drug discovery and development, and the company is among the first in the world to embrace the AI technologies in tools in drug discoveries. Now the company realized that it could use AI on Intel Xeon architecture to launch a new system for COVID-19 basic and clinical research.
Insilico Medicine came up with COVIDomic, a foundational technology that enables scientists to use anonymized patient data to integrate with a variety o…
-
Noosa News22 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News20 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News21 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
General18 hours agoDairy farmers devastated by floods across parts of New South Wales